ADVERTISEMENT
Search

From the Desk of the CEO

Empowering Pharmacy Voices, Inspiring Change

Discover insights, stories, and expertise from pharmacists shaping the future of healthcare. Explore thought-provoking discussions, industry trends, and personal experiences that define the pharmacy profession.

Posted: May 3, 2021

FDA approves higher dosage of naloxone nasal spray

On April 30, FDA announced the approval of a higher dosage of naloxone hydrochloride nasal spray (Kloxxado—Hikma Pharmaceuticals) to treat opioid overdose. The newly approved product delivers 8 mg of naloxone into the nasal cavity, compared with previously approved 2- and 4-mg naloxone nasal spray products.

Read more
Posted: Apr 26, 2021

CDC recommends pregnant women get COVID-19 vaccine

Pregnant women should get the COVID-19 vaccine, said CDC. CDC Director Rochelle Walensky, MD, noted at a White House briefing that vaccination surveillance systems found “no safety concerns” for more than 35,000 women in their third trimester or for their babies.

Read more
Posted: Apr 26, 2021

STDs reach all time high

Annual cases of sexually transmitted diseases (STDs) in the United States continued to increase in 2019, hitting an all-time high for the sixth consecutive year, according to new CDC data.

Read more
Posted: Apr 19, 2021

CDC: Overdose deaths surged during pandemic

More than 87,000 Americans died from drug overdoses in the 12-month period that ended in September 2020, according to preliminary CDC data, which indicate that the U.S. drug overdose mortality rate increased last year.

Read more
Posted: Apr 16, 2021

How to talk to patients about the J&J vaccine

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson, J&J) vaccine remains in place.

Read more
First789101112131416
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT